Bausch & Lomb Corp (BLCO) stock
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3028% below fair value
$20.69−0.26 (-1.24%)
Close on Nov 19, 2026Market cap $7.40BP/E –Yield –
Bausch & Lomb free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Bausch & Lomb's free cash flow for the twelve months ending Sep 30, 2026 was $252.00M. For fiscal 2025 it was -$66.00M. The highest annual figure on record is $680.00M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$66.00M | – |
| FY2024 | Dec 31, 2024 | -$59.00M | – |
| FY2023 | Dec 31, 2023 | -$198.00M | -216.5% |
| FY2022 | Dec 31, 2022 | $170.00M | -75.0% |
| FY2021 | Dec 31, 2021 | $680.00M | +152.8% |
| FY2020 | Dec 31, 2020 | $269.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $178.00M | +182.5% |
| Q2 FY2026 | Jun 30, 2026 | $82.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$68.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $60.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $63.00M | -33.0% |
| Q2 FY2025 | Jun 30, 2025 | -$54.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$135.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$70.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $94.00M | +526.7% |
| Q2 FY2024 | Jun 30, 2024 | -$57.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$69.00M | -163.3% |
| Q3 FY2023 | Sep 30, 2023 | $15.00M | – |
| Q2 FY2023 | Jun 30, 2023 | -$51.00M | -141.8% |
| Q1 FY2023 | Mar 31, 2023 | -$93.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $109.00M | +9.0% |
| Q3 FY2022 | Sep 30, 2022 | -$22.00M | -109.5% |
| Q2 FY2022 | Jun 30, 2022 | $122.00M | -40.5% |
| Q1 FY2022 | Mar 31, 2022 | -$39.00M | -127.3% |
| Q4 FY2021 | Dec 31, 2021 | $100.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $232.00M | – |
| Q2 FY2021 | Jun 30, 2021 | $205.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $143.00M | – |
See a number that looks wrong?